L Wallentin
Overview
Explore the profile of L Wallentin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
2071
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olszowka M, Held C, Hadziosmanovic N, Denchev S, Manolis A, Wallentin L, et al.
J Intern Med
. 2021 May;
290(2):392-403.
PMID: 33971052
Background: Sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnoea, are associated with increased cardiovascular (CV) risk. However, it is not known whether individual questions used for SRBD screening are associated...
2.
Rosjo H, Hijazi Z, Omland T, Westerbergh J, Lyngbakken M, Alexander J, et al.
J Intern Med
. 2020 May;
288(2):248-259.
PMID: 32350915
Background: Cardiac troponin T (cTnT) and I (cTnI) concentrations provide strong prognostic information in anticoagulated patients with atrial fibrillation (AF). Whether the associations between cardiac troponin concentrations and mortality and...
3.
Proietti M, Hijazi Z, Andersson U, Connolly S, Eikelboom J, Ezekowitz M, et al.
J Intern Med
. 2017 Oct;
283(3):282-292.
PMID: 29044861
Background: Oral anticoagulation is the mainstay of stroke prevention in atrial fibrillation (AF), but must be balanced against the associated bleeding risk. Several risk scores have been proposed for prediction...
4.
Hagstrom E, Norlund F, Stebbins A, Armstrong P, Chiswell K, Granger C, et al.
J Intern Med
. 2017 Sep;
283(1):83-92.
PMID: 28960596
Objectives: Assess the risk of ischaemic events associated with psychosocial stress in patients with stable coronary heart disease (CHD). Methods: Psychosocial stress was assessed by a questionnaire in 14 577...
5.
Westenbrink B, Alings M, Connolly S, Eikelboom J, Ezekowitz M, Oldgren J, et al.
J Thromb Haemost
. 2015 Feb;
13(5):699-707.
PMID: 25683276
Background: Anemia may predispose to thromboembolic events or bleeding in anticoagulated patients with atrial fibrillation (AF). Objectives: To investigate whether anemia is associated with thromboembolic events and bleeding in patients...
6.
Janzon M, James S, Cannon C, Storey R, Mellstrom C, Nicolau J, et al.
Heart
. 2014 Sep;
101(2):119-25.
PMID: 25227704
Objective: To investigate the cost effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes (ACS) in the Platelet Inhibition and Patient Outcomes (PLATO) study who were scheduled for...
7.
Christersson C, Wallentin L, Andersson U, Alexander J, Ansell J, De Caterina R, et al.
J Thromb Haemost
. 2014 Jun;
12(9):1401-12.
PMID: 24942912
Background: D-dimer is related to adverse outcomes in arterial and venous thromboembolic diseases. Objectives: To evaluate the predictive value of D-dimer level for stroke, other cardiovascular events, and bleeds, in...
8.
Wallentin L, Himmelmann A, Storey R, Steg P, Harrington R
Thromb Haemost
. 2014 May;
112(1):12-4.
PMID: 24816949
No abstract available.
9.
De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, et al.
Thromb Haemost
. 2013 May;
109(5):769-86.
PMID: 23636477
Anticoagulants are a mainstay of cardiovascular therapy, and parenteral anticoagulants have widespread use in cardiology, especially in acute situations. Parenteral anticoagulants include unfractionated heparin, low-molecular-weight heparins, the synthetic pentasaccharides fondaparinux,...
10.
Liesenfeld K, Lehr T, Dansirikul C, Reilly P, Connolly S, Ezekowitz M, et al.
J Thromb Haemost
. 2011 Oct;
9(11):2168-75.
PMID: 21972820
Background: Dabigatran etexilate (DE) is an orally absorbed prodrug of dabigatran, a thrombin inhibitor that exerts potent anticoagulant and antithrombotic activity. Objectives: To characterize the pharmacokinetics of dabigatran in patients...